The Australian laparoscopic non robotic radical prostatectomy experience – analysis of 2943 cases (USANZ supplement). (23rd September 2016)

• Record Type: Journal Article
• Authors: Louie‐Johnsun, Mark William; Handmer, Marcus M.; Calopedos, Ross John Spero; Chabert, Charles; Cohen, Ronald J.; Gianduzzo, Troy R. J.; Kearns, Paul A.; Moon, Daniel A.; Ooi, Jason; Shannon, Tom; Sofield, David; Tan, Andrew H. H.
• Is Part Of: BJU international. Volume 118(2016:Oct.)Supplement 3
• Page Start: 43
• Page End: 48
• Publication Date: 2016-09-23
• Subjects: laparoscopy -- prostate cancer -- radical prostatectomy -- outcome; Genitourinary organs -- Diseases -- Periodicals; Genitourinary organs -- Surgery -- Periodicals; Urology -- Periodicals; 616.6
• DOI: 10.1111/bju.13610
• Languages: English
• ISSNs: 1464-4096

Abstract

Abstract : Objectives: To analyse the Australian experience of high‐volume Fellowship‐trained Laparoscopic Radical Prostatectomy (LRP) surgeons. Materials and Methods: 2943 LRP cases were performed by nine Australian surgeons. The inclusion criteria were a prospectively collected database with a minimum of 100 consecutive LRP cases. The surgeons' LRP experience commenced at various times from July 2003 to September 2009. Data were analysed for demographic, peri‐operative, oncological and functional outcomes. Results: The mean age of patients were 61.5 years and mean preoperative PSA 7.4 ng/ml. Mean operating time was 168 minutes with conversion to open surgery in 0.5% and a blood transfusion rate of 1.1%. Overall mean length of stay was 2.5 days. 73.6% of pathological specimens were pT2 and 86.3% had Gleason Score >7. Overall positive surgical margins (PSM) occurred in 15.9% with pT2 PSM 9.8%, pT3a PSM 30.8% and pT3b PSM 39.2%. Mean urinary continence at 12 months was 91.4% (data available from five surgeons). Mean 12 months potency after bilateral nerve spare was 47.2% (data available from four surgeons). Biochemical recurrence occurred in 10.6% (mean follow up 17 months). Conclusion: The Australian experience of Fellowship trained surgeons performing LRP demonstrates favourable peri‐operative, oncological and functional outcomes in comparison to published data for open, laparoscopic and robotic assisted radical prostatectomy. In our Australian centres, LRP remains an acceptable minimally invasive surgical treatment for prostate cancer despite the increasing use of robotic assisted surgery.